Summary
Cardinal Health, Inc. reported strong revenue growth for the first quarter of fiscal year 2001, with total revenue increasing by 20% to $8.7 billion compared to the prior year period. This growth was driven by solid performance across its key segments, particularly Pharmaceutical Distribution and Provider Services, which saw a 22% increase in operating revenue. The company also reported a significant increase in net earnings, up 42% year-over-year to $173.2 million, translating to diluted earnings per share of $0.61, a notable rise from $0.43 in the previous year. This improved profitability, alongside controlled SG&A expenses as a percentage of revenue, indicates effective operational management and integration of recent acquisitions. The balance sheet shows continued investment in growth, with total assets increasing and a healthy rise in shareholders' equity. However, investors should note the significant increase in inventories and trade receivables, which are partially offset by increased accounts payable. The company also highlighted its strong liquidity position and access to capital through its commercial paper program and credit facility, underscoring its ability to fund ongoing operations and expansion. While merger-related costs have decreased, they continue to impact the bottom line, though their net effect on earnings is becoming less pronounced.
Key Highlights
- 1Total revenue surged by 20% to $8.7 billion for the three months ended September 30, 2000, compared to $6.8 billion in the prior year period.
- 2Net earnings increased by a substantial 42% to $173.2 million, up from $122.0 million in the same period last year.
- 3Diluted earnings per share rose to $0.61 from $0.43, reflecting improved profitability.
- 4The Pharmaceutical Distribution and Provider Services segment continues to be the largest revenue driver, growing 22% year-over-year.
- 5Selling, general, and administrative (SG&A) expenses decreased as a percentage of operating revenue to 6.10% from 6.71%, indicating improved operational efficiency.
- 6The company acquired Bergen Brunswig Medical Corporation (BBMC) during the quarter, contributing to revenue growth in the Medical-Surgical Products and Services segment.
- 7Total assets grew to $11.2 billion from $10.3 billion, reflecting continued investment and acquisitions.